CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $9.95 | $30K | 227,775 |
| 2022-11-18 | Drutz David Director | Option exercise | +139 | $2.40 | $334 | 20,151 |
| 2022-11-18 | Drutz David Director | Option exercise · Stock Options (option to buy) | −139 | 0 | ||
| 2022-10-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $12.77 | $38K | 230,782 |
| 2022-09-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,008 | $12.77 | $38K | 233,789 |
| 2022-09-29 | Jorkasky Diane Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | Drutz David Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | Pisano Wayne Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | Schafer Klaus Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | SAYARE MITCHEL Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-09-29 | Hodges Philip Director | Grant or award · Stock Options (option to buy) | +23,500 | 23,500 | ||
| 2022-08-31 | Garg Vipin K President and CEO | Sale | −20,000 | $20.02 | $400K | 236,797 |
| 2022-08-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $18.94 | $57K | 256,797 |
| 2022-08-12 | GILL JOHN Director | Sale | −2,714 | $15.00 | $41K | 2,771 |
| 2022-08-12 | Garg Vipin K President and CEO | Sale | −15,000 | $15.06 | $226K | 259,804 |
| 2022-07-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +1,076 | $6.86 | $7K | 12,621 |
| 2022-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +732 | $6.86 | $5K | 9,037 |
| 2022-07-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award | +1,366 | $6.86 | $9K | 1,366 |
| 2022-07-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $12.01 | $36K | 274,804 |
Page 15 of 29 · 568 trades